Dexcom Announces Upcoming Conference Presentations
30 Agosto 2023 - 9:30AM
Business Wire
DexCom, Inc. (NASDAQ:DXCM) today announced that management will
present an update on the company at the following upcoming investor
conferences:
- Jereme Sylvain, Executive Vice President and Chief Financial
Officer, will present on behalf of the company at the 2023 Wells
Fargo Healthcare Conference on Wednesday, September 6, 2023 at
3:45pm (EDT).
- Sean Christensen, Vice President, Finance and Investor
Relations, will present on behalf of the company at the Baird 2023
Global Healthcare Conference on Wednesday, September 13, 2023 at
9:40am (EDT).
Links to the webcast will be available on the Dexcom Investor
Relations website at investors.dexcom.com and will be archived
there for future reference.
About DexCom, Inc.
DexCom, Inc. empowers people to take real-time control of health
through innovative continuous glucose monitoring systems.
Headquartered in San Diego, Calif., and with operations across
Europe and select parts of Asia/Oceania, Dexcom has emerged as a
leader of diabetes care technology. By listening to the needs of
users, caregivers, and providers, Dexcom works to simplify and
improve diabetes management around the world. For more information
on Dexcom, visit www.dexcom.com.
Category: IR
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230830144125/en/
DexCom, Inc. Sean Christensen Vice President – Finance
and Investor Relations investor-relations@dexcom.com (858)
200-0200
DexCom (NASDAQ:DXCM)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
DexCom (NASDAQ:DXCM)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024